Cargando…

Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour

BACKGROUND: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment. CASE PRESENTATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakha, Serena, Bayliss, Clare, Sanderson, Frances, Smith, Richard, Seckl, Michael, Savage, Philip
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909206/
https://www.ncbi.nlm.nih.gov/pubmed/20587067
http://dx.doi.org/10.1186/1471-2407-10-338
_version_ 1782184286836752384
author Rakha, Serena
Bayliss, Clare
Sanderson, Frances
Smith, Richard
Seckl, Michael
Savage, Philip
author_facet Rakha, Serena
Bayliss, Clare
Sanderson, Frances
Smith, Richard
Seckl, Michael
Savage, Philip
author_sort Rakha, Serena
collection PubMed
description BACKGROUND: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment. CASE PRESENTATION: In this case of a 36 year old woman, the elevated hCG level at presentation was helpful in making a clinical diagnosis of OGCT in a patient too unwell to permit a tissue diagnosis. Cisplatin based combination chemotherapy produced an initial normalisation of the hCG level, but later in treatment the patient developed new cerebral lesions and a rising serum hCG suggestive of disease progression. Further investigations suggested that the CNS lesions were cerebral TB and that the low levels of hCG elevations was likely to be pituitary in origin. Chemotherapy treatment was continued along with anti-tuberculous therapy and 24 months after successful completion of therapy the patient remains disease free. CONCLUSIONS: In the treatment of cancer patients it may be helpful to consider the potential non-malignant causes of new CNS lesions and that low hCG elevations may result from physiology rather than pathology in selected cases.
format Text
id pubmed-2909206
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29092062010-07-24 Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour Rakha, Serena Bayliss, Clare Sanderson, Frances Smith, Richard Seckl, Michael Savage, Philip BMC Cancer Case Report BACKGROUND: Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be helpful in the diagnosis and monitoring the response to treatment. CASE PRESENTATION: In this case of a 36 year old woman, the elevated hCG level at presentation was helpful in making a clinical diagnosis of OGCT in a patient too unwell to permit a tissue diagnosis. Cisplatin based combination chemotherapy produced an initial normalisation of the hCG level, but later in treatment the patient developed new cerebral lesions and a rising serum hCG suggestive of disease progression. Further investigations suggested that the CNS lesions were cerebral TB and that the low levels of hCG elevations was likely to be pituitary in origin. Chemotherapy treatment was continued along with anti-tuberculous therapy and 24 months after successful completion of therapy the patient remains disease free. CONCLUSIONS: In the treatment of cancer patients it may be helpful to consider the potential non-malignant causes of new CNS lesions and that low hCG elevations may result from physiology rather than pathology in selected cases. BioMed Central 2010-06-29 /pmc/articles/PMC2909206/ /pubmed/20587067 http://dx.doi.org/10.1186/1471-2407-10-338 Text en Copyright ©2010 Rakha et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rakha, Serena
Bayliss, Clare
Sanderson, Frances
Smith, Richard
Seckl, Michael
Savage, Philip
Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
title Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
title_full Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
title_fullStr Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
title_full_unstemmed Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
title_short Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
title_sort pituitary hcg production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909206/
https://www.ncbi.nlm.nih.gov/pubmed/20587067
http://dx.doi.org/10.1186/1471-2407-10-338
work_keys_str_mv AT rakhaserena pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour
AT baylissclare pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour
AT sandersonfrances pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour
AT smithrichard pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour
AT secklmichael pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour
AT savagephilip pituitaryhcgproductionandcerebraltuberculosismimickingdiseaseprogressionduringchemotherapyforanadvancedovariangermcelltumour